These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 385392)
1. Mechanisms of action of antidepressant drugs. Hamon M Adv Biosci; 1978 Jul 24-25; 21():117-28. PubMed ID: 385392 [No Abstract] [Full Text] [Related]
2. The GABA hypothesis of depression and antidepressant drug action. Bartholini G; Lloyd KG; Scatton B; Zivkovic B; Morselli PL Psychopharmacol Bull; 1985; 21(3):385-8. PubMed ID: 2994153 [No Abstract] [Full Text] [Related]
3. Monoamine receptor sensitivity and the mechanism of action of antidepressant treatment. Psychopharmacol Bull; 1982 Jul; 18(3):130-55. PubMed ID: 6292986 [No Abstract] [Full Text] [Related]
4. Neurochemical and neuropharmacological investigations into the mechanisms of action of bupropion . HCl--a new atypical antidepressant agent. Ferris RM; Maxwell RA; Cooper BR; Soroko FE Adv Biochem Psychopharmacol; 1982; 31():277-86. PubMed ID: 6282058 [TBL] [Abstract][Full Text] [Related]
5. [Neurochemical and behavioral study on the mechanism of the antidepressant and anxiolytic effect of co-administration of lithium and monoamine oxidase inhibitors]. Kitaichi Y Hokkaido Igaku Zasshi; 2004 Jan; 79(1):93-101. PubMed ID: 14978979 [No Abstract] [Full Text] [Related]
6. [Effect of antidepressants on the cardiovascular system]. Kopera H Med Klin; 1979 Sep; 74(38):1339-45. PubMed ID: 388171 [No Abstract] [Full Text] [Related]
7. Histochemical fluorescence detection of changes in central monoamine neurones provoked by drugs acting on the CNS. Fuxe K; Hökfelt T Triangle; 1971; 10(3):73-84. PubMed ID: 5138525 [No Abstract] [Full Text] [Related]
9. Effect of drugs on amines in the CNS. Sulser F; Sanders-Bush E Annu Rev Pharmacol; 1971; 11():209-30. PubMed ID: 4948498 [No Abstract] [Full Text] [Related]
10. Use of monoamine oxidase inhibitors in chronic neurodegeneration. Riederer P; Müller T Expert Opin Drug Metab Toxicol; 2017 Feb; 13(2):233-240. PubMed ID: 27998194 [TBL] [Abstract][Full Text] [Related]
11. Pharmacological profile and mechanism of action of antidepressant drugs. Maj J Acta Physiol Pol; 1987; 38(4):289-301. PubMed ID: 2898869 [No Abstract] [Full Text] [Related]
12. Use of dopamine-beta-hydroxylase-deficient mice to determine the role of norepinephrine in the mechanism of action of antidepressant drugs. Cryan JF; Dalvi A; Jin SH; Hirsch BR; Lucki I; Thomas SA J Pharmacol Exp Ther; 2001 Aug; 298(2):651-7. PubMed ID: 11454927 [TBL] [Abstract][Full Text] [Related]
13. The neuro- and cardiovascular pharmacology of RS-51324, a potential antidepressant. Wallach MB; Alps BJ; Roszkowski AP; Waterbury LD Prog Neuropsychopharmacol; 1980; 4(6):569-84. PubMed ID: 7220671 [No Abstract] [Full Text] [Related]
14. Pharmacological and biochemical properties of BRL 14342, a novel potential antidepressant drug. Clark MS; Johnson AM; McClelland GR; Nelson DR Neuropharmacology; 1980 Dec; 19(12):1207-8. PubMed ID: 7442949 [No Abstract] [Full Text] [Related]
15. The use of amphetamine induced stereotyped behaviour as a model for the experimental evaluation of antiparkinson agents. Costall B; Naylor RJ; Wright T Arzneimittelforschung; 1972 Jul; 22(7):1178-83. PubMed ID: 4404343 [No Abstract] [Full Text] [Related]